CSIMarket Company Name, Ticker, Suppliers, else..
 
Zimmer Biomet Holdings Inc   (NYSE: ZBH)
Other Ticker:  
 
 
Price: $107.4250 $0.52 0.482%
Day's High: $107 Week Perf: -0.56 %
Day's Low: $ 106.70 30 Day Perf: -2.29 %
Volume (M): 21 52 Wk High: $ 133.90
Volume (M$): $ 2,269 52 Wk Avg: $115.20
Open: $108.58 52 Wk Low: $101.47



 Market Capitalization (Millions $) 21,807
 Shares Outstanding (Millions) 203
 Employees 18,000
 Revenues (TTM) (Millions $) 7,595
 Net Income (TTM) (Millions $) 1,085
 Cash Flow (TTM) (Millions $) 277
 Capital Exp. (TTM) (Millions $) 335

Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc. is a prominent global medical device company that specializes in the design, manufacturing, and marketing of orthopedic and musculoskeletal healthcare products. The company offers a comprehensive portfolio of products, including joint replacement devices, surgical instruments, and biologics, aimed at improving patient outcomes in the treatment of musculoskeletal disorders.

The firms offerings cover various categories, including hip and knee replacements, trauma products, and spine and dental solutions. Zimmer Biomet places a strong emphasis on innovation and invests significantly in research and development to create advanced technologies and products that enhance surgical efficiency and patient recovery.

Operating in over 100 countries, Zimmer Biomet has established itself as a key player in the orthopedic market, serving healthcare professionals with a focus on delivering high-quality products and solutions. The company is dedicated to improving the quality of life for patients through its continued commitment to addressing the evolving needs of the healthcare community.


   Company Address: 345 East Main Street Warsaw 46580 IN
   Company Phone Number: 373-3333   Stock Exchange / Ticker: NYSE ZBH


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BSX        1.08% 
EW        1.91% 
ISRG   -0.29%    
MDT   -1.23%    
SYK   -2.26%    
TFX   -0.39%    
• View Complete Report
   



Stocks on the Move

Zimmer Biomet Holdings Examining Recent Developments and Investment Potential

Published Wed, Jun 26 2024 5:03 PM UTC

In recent news surrounding Zimmer Biomet Holdings (NYSE:ZBH), several key developments have emerged, shedding light on the company s performance, investor sentiment, and upcoming dividend. As investors assess the potential of Zimmer Biomet Holdings as an investment option, it is crucial to evaluate these significant factors before making any investment decisions.Assessing Sh...
Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc's Fiscal Third Quarter Sees Mixed Results with 16.3% Drop in Earnings per Share

Zimmer Biomet Holdings Inc Faces Mixed Performance in Fiscal Third Quarter
In the fiscal third quarter of 2023, medical equipment and supplies company Zimmer Biomet Holdings Inc (ZBH) reported different earnings results. While the company experienced a 5.019% increase in revenue to $1.75 billion compared to the previous year, its income fell by -16.3% to $0.77 per share from $0.92 per share in the prior year reporting period.
The revenue decrease of -6.205% from the previous quarter, coupled with a -23% decline in income from $1.00 per share, paints a varied picture for investors. However, Zimmer Biomet Holdings Inc remains determined to prioritize considered spending and investments, development, and personnel to create long-term value for stakeholders.
Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc Reports Impressive 36.99% Surge in Profit Per Share, Alongside 4.928% Revenue Boost in Q2 2023 Earnings Season

Zimmer Biomet Holdings Inc, a prominent Medical Equipment & Supplies company, has experienced some significant developments in its stock performance in recent trading days. Over the course of the last five trading days, its stock saw a decline of -5.39%. However, despite this short-term setback, the year-to-date performance stands at a positive 3.92%. Currently, Zimmer Biomet Holdings Inc's stock is trading on the NYSE at a price 6.2% higher than its 52-week average.
Examining the financial results from the quarter ending on June 30, 2023, Zimmer Biomet Holdings Inc displayed impressive figures and growth in various areas. Notably, the company's earnings per share (EPS) significantly outpaced revenue growth, with a surge of 36.99% to reach $1.00 per share. Revenue also witnessed a solid advancement of 4.928% from the corresponding quarter a year before, increasing to $1.87 billion. In the prior quarter, the company achieved revenue of $1.83 billion and earned $1.11 per share.
Zimmer Biomet Holdings Inc

Strong Eps Underlines Double Digits revenue rise at in the first quarter of 2023

Zimmer Biomet Holdings Inc's latest financial report for the first quarter of 2023 showed improvements in its Return on Equity, with the ROE standing at 3.71% compared to the previous quarter's 1.92%. Despite this, the figure remains below the company's average return on equity of 4.57%. While nine other companies in the Biotechnology & Pharmaceuticals industry had a higher ROE, Zimmer Biomet's overall ranking for the metric improved in the first quarter, moving up to 529 from 2305 in the fourth quarter of 2022.
Investors will be pleased to note that Zimmer Biomet's earnings per share soared by an impressive 1485.71% to $1.11 in the first three months of 2023. Revenue also saw a significant increase, rising 10.089% to $1.83 billion, compared to the same period in the prior year. Net profits came in at $232.7 million, up from $14.4 million a year ago, reflecting a 1515.97% growth.






Zimmer Biomet Holdings Inc's Segments
US    57.69 % of total Revenue
International    42.31 % of total Revenue
Americas    62.27 % of total Revenue
EMEA    20.62 % of total Revenue
Asia Pacific    17.1 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com